122 related articles for article (PubMed ID: 35835092)
21. Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience.
Couñago F; Recio M; Maldonado A; Del Cerro E; Díaz-Gavela AA; Thuissard IJ; Sanz-Rosa D; Marcos FJ; Olaciregui K; Mateo M; Cerezo L
Cancer Imaging; 2016 Dec; 16(1):42. PubMed ID: 27927229
[TBL] [Abstract][Full Text] [Related]
22. 18F-Fluorocholine PET/CT Complementing the Role of Dynamic Contrast-Enhanced MRI for Providing Comprehensive Diagnostic Workup in Prostate Cancer Patients With Suspected Relapse Following Radical Prostatectomy.
Vadi SK; Singh B; Basher RK; Watts A; Sood AK; Lal A; Kakkar N; Singh SK
Clin Nucl Med; 2017 Aug; 42(8):e355-e361. PubMed ID: 28525448
[TBL] [Abstract][Full Text] [Related]
23. Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound.
Chen YH; Chen HT; Lee MC; Liu SH; Wang LY; Lue KH; Chan SC
Ann Nucl Med; 2020 Aug; 34(8):527-537. PubMed ID: 32436180
[TBL] [Abstract][Full Text] [Related]
24. 18F-Fluorocholine PET/CT in the Prediction of Molecular Subtypes and Prognosis for Gliomas.
García Vicente AM; Pérez-Beteta J; Amo-Salas M; Pena Pardo FJ; Villena Martín M; Sandoval Valencia H; Mollejo Villanueva M; Barbella R; Klein Zampaña CJ; Borrás Moreno JM; Soriano Castrejón ÁM; Pérez-García VM
Clin Nucl Med; 2019 Oct; 44(10):e548-e558. PubMed ID: 31306196
[TBL] [Abstract][Full Text] [Related]
25. Prognosis Related to Metastatic Burden Measured by ¹⁸F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer.
Kwee SA; Lim J; Watanabe A; Kromer-Baker K; Coel MN
J Nucl Med; 2014 Jun; 55(6):905-10. PubMed ID: 24676753
[TBL] [Abstract][Full Text] [Related]
26. 11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas.
D'Souza MM; Sharma R; Jaimini A; Panwar P; Saw S; Kaur P; Mondal A; Mishra A; Tripathi RP
Clin Nucl Med; 2014 Sep; 39(9):791-8. PubMed ID: 25036022
[TBL] [Abstract][Full Text] [Related]
27. Comparison of
Gauthé M; Zarca K; Aveline C; Lecouvet F; Balogova S; Cussenot O; Talbot JN; Durand-Zaleski I
BMC Med Imaging; 2020 Mar; 20(1):25. PubMed ID: 32122345
[TBL] [Abstract][Full Text] [Related]
28. False-Positive 18F-PSMA-1007 and True-Negative 18F-Fluorocholine PET/CT Splenic Hemangioma.
Panagiotidis E; Paschali A; Xourgia X; Chatzipavlidou V
Clin Nucl Med; 2020 Dec; 45(12):960-961. PubMed ID: 33065626
[TBL] [Abstract][Full Text] [Related]
29. 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Talbot JN; Garderet L
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1995-2004. PubMed ID: 27121691
[TBL] [Abstract][Full Text] [Related]
30. Performance of quantitative measurements in [
Jacquet-Francillon N; Morelec I; Germain N; Prades JM; Habouzit V; Mariat C; Bonnefoy PB; Prevot N
Front Med (Lausanne); 2022; 9():956580. PubMed ID: 35983092
[TBL] [Abstract][Full Text] [Related]
31. Ischemic Complications After High-Grade Glioma Resection Could Interfere With Residual Tumor Detection With 18F-Fluorocholine PET/CT.
García Vicente AM; Rodriguez Muñoz MJ; Pena Pardo FJ; Martinez Madrigal MM; Soriano Castrejón A
Clin Nucl Med; 2019 Feb; 44(2):e76-e84. PubMed ID: 30516681
[TBL] [Abstract][Full Text] [Related]
32. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
[TBL] [Abstract][Full Text] [Related]
33. [Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence].
Poncet D; Arnoux V; Descotes JL; Rambeaud JJ; Verry C; Terrier N; Boillot B; Dubreuil J; Lanchon C; Carnicelli D; Fiard G; Long JA
Prog Urol; 2015 May; 25(6):325-30. PubMed ID: 25748788
[TBL] [Abstract][Full Text] [Related]
34. ¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study.
Lezaic L; Rep S; Sever MJ; Kocjan T; Hocevar M; Fettich J
Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2083-9. PubMed ID: 25063039
[TBL] [Abstract][Full Text] [Related]
35.
Christakis I; Khan S; Sadler GP; Gleeson FV; Bradley KM; Mihai R
Ann R Coll Surg Engl; 2019 Sep; 101(7):501-507. PubMed ID: 31305126
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Accuracy of
Murtojärvi S; Malaspina S; Kinnunen I; Tuokkola T; Honka MJ; Saunavaara V; Tolvanen T; Schrey A; Kemppainen J
Contrast Media Mol Imaging; 2022; 2022():8676787. PubMed ID: 36082064
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and therapeutic impact of PET/CT with 18F-DCFPyL versus 18F-Fluorocholine in initial staging of intermediate-/high-risk prostate cancer: a pilot study.
Lucas Lucas C; García Zoghby L; Amo-Salas M; Soriano Castrejón ÁM; García Vicente AM
Ann Nucl Med; 2023 Oct; 37(10):551-560. PubMed ID: 37532975
[TBL] [Abstract][Full Text] [Related]
38. Impact of sodium
Gauthé M; Aveline C; Lecouvet F; Michaud L; Rousseau C; Tassart M; Cussenot O; Talbot JN; Durand-Zaleski I
World J Urol; 2019 Aug; 37(8):1587-1595. PubMed ID: 30382380
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
Chalaye J; Costentin CE; Luciani A; Amaddeo G; Ganne-Carrié N; Baranes L; Allaire M; Calderaro J; Azoulay D; Nahon P; Seror O; Mallat A; Soussan M; Duvoux C; Itti E; Nault JC
J Hepatol; 2018 Aug; 69(2):336-344. PubMed ID: 29518452
[TBL] [Abstract][Full Text] [Related]
40. 18F-Fluorocholine PET/CT, Brain MRI, and 5-Aminolevulinic Acid for the Assessment of Tumor Resection in High-Grade Glioma.
García Vicente AM; Jiménez Aragón F; Villena Martín M; Jiménez Londoño GA; Borrás Moreno JM
Clin Nucl Med; 2017 Jun; 42(6):e300-e303. PubMed ID: 28319501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]